BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18946937)

  • 21. Salvage radiotherapy with or without concurrent chemotherapy for pelvic recurrence after hysterectomy alone for early-stage uterine cervical cancer.
    Kim SW; Chun M; Ryu HS; Chang SJ; Kong TW; Lee EJ; Lee YH; Oh YT
    Strahlenther Onkol; 2017 Jul; 193(7):534-542. PubMed ID: 28357468
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical analysis of 32 cases with neuroendocrine carcinoma of the uterine cervix in early-stage disease].
    Wang Z; Wu L; Yao H; Sun Y; Li X; Li B; Zhang R; Ma S; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 2015 Mar; 50(3):198-203. PubMed ID: 26268410
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pre-treatment MRI minimum apparent diffusion coefficient value is a potential prognostic imaging biomarker in cervical cancer patients treated with definitive chemoradiation.
    Marconi DG; Fregnani JH; Rossini RR; Netto AK; Lucchesi FR; Tsunoda AT; Kamrava M
    BMC Cancer; 2016 Jul; 16():556. PubMed ID: 27469349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of the prognostic impact of tumor embolization before definitive radiotherapy for cervical carcinoma.
    Kapp KS; Poschauko J; Tauss J; Berghold A; Oechs A; Lahousen M; Petru E; Winter R; Kapp DS
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1399-404. PubMed ID: 16029799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Outcomes and prognostic factors of advanced squamous cervical cancer after concurrent chemoradiotherapy].
    Binbin T; Lingying W; Manni H; Jusheng A; Ning L
    Zhonghua Fu Chan Ke Za Zhi; 2014 May; 49(5):348-54. PubMed ID: 25030731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staging of advanced cervical carcinoma using MRI-predictors of outcome after radical radiotherapy.
    Taylor MB; Carrington BM; Davidson SE; Swindell R; Lawrance JA
    Clin Radiol; 2003 Jul; 58(7):532-41. PubMed ID: 12834636
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume.
    Trattner M; Graf AH; Lax S; Forstner R; Dandachi N; Haas J; Pickel H; Reich O; Staudach A; Winter R
    Gynecol Oncol; 2001 Jul; 82(1):11-6. PubMed ID: 11426955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of treatment failure following radiotherapy with combination chemotherapy for patients with high-risk stage IIB cervical carcinoma.
    Park TK; Kwon JY; Kim SW; Kim SH; Kim SN; Kim GE
    Int J Clin Oncol; 2004 Apr; 9(2):120-4. PubMed ID: 15108044
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic value of maximum standardized uptake value measured by pretreatment 18F-FDG PET/CT in locally advanced head and neck squamous cell carcinoma.
    Cacicedo J; Fernandez I; Del Hoyo O; Navarro A; Gomez-Iturriaga A; Pijoan JI; Martinez-Indart L; Escudero J; Gomez-Suarez J; de Zarate RO; Perez JF; Bilbao P; Rades D
    Clin Transl Oncol; 2017 Nov; 19(11):1337-1349. PubMed ID: 28540535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
    Singh P; Tripcony L; Nicklin J
    Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of the prognostic value of F-18 FDG PET/CT metabolic parameters of primary tumors and MRI findings in patients with locally advanced cervical cancer treated with concurrent chemoradiotherapy.
    Dag Z; Yilmaz B; Dogan AK; Aksan DU; Ozkurt H; Kızılkaya HO; Arslan D
    Brachytherapy; 2019; 18(2):154-162. PubMed ID: 30594422
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Magnetic resonance imaging features of tumor and lymph node to predict clinical outcome in node-positive cervical cancer: a retrospective analysis.
    Park SH; Hahm MH; Bae BK; Chong GO; Jeong SY; Na S; Jeong S; Kim JC
    Radiat Oncol; 2020 Apr; 15(1):86. PubMed ID: 32312283
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic value of 18F-fluorodeoxyglucose uptake in pelvic lymph nodes in patients with cervical cancer treated with definitive chemoradiotherapy.
    Onal C; Guler OC; Reyhan M; Yapar AF
    Gynecol Oncol; 2015 Apr; 137(1):40-6. PubMed ID: 25641567
    [TBL] [Abstract][Full Text] [Related]  

  • 35. P27 as a prognostic factor of early cervical carcinoma.
    Bouda J; Hes O; Koprivova M; Pesek M; Svoboda T; Boudova L
    Int J Gynecol Cancer; 2013 Jan; 23(1):164-9. PubMed ID: 23221604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retrospective analysis for predictors of parametrial involvement in IB cervical cancer.
    Kubota S; Kobayashi E; Kakuda M; Matsuzaki S; Ueda Y; Yoshino K; Kimura T
    J Obstet Gynaecol Res; 2019 Mar; 45(3):679-685. PubMed ID: 30565810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matched-case comparison for the role of surgery in FIGO stage Ib1-IIa squamous cell carcinoma of cervix and suspicious para-aortic lymph node metastasis.
    Kim HS; Park NH; Wu HG; Cho JY; Chung HH; Kim JW; Song YS; Kim SH; Kang SB
    Ann Surg Oncol; 2009 Jan; 16(1):133-9. PubMed ID: 18979134
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Utility of Pretreatment and Posttreatment Lymphopenia in Cervical Squamous Cell Carcinoma Patients Treated With Definitive Chemoradiotherapy.
    Onal C; Yildirim BA; Guler OC; Mertsoylu H
    Int J Gynecol Cancer; 2018 Oct; 28(8):1553-1559. PubMed ID: 30247248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumor Size at Magnetic Resonance Imaging Association With Lymph Node Metastasis and Lymphovascular Space Invasion in Resectable Cervical Cancer: A Multicenter Evaluation of Surgical Specimens.
    Chen XL; Chen GW; Xu GH; Ren J; Li ZL; Pu H; Li H
    Int J Gynecol Cancer; 2018 Oct; 28(8):1545-1552. PubMed ID: 30044321
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The long-term efficacy of neoadjuvant chemotherapy followed by radical hysterectomy compared with radical surgery alone or concurrent chemoradiotherapy on locally advanced-stage cervical cancer.
    Yin M; Zhao F; Lou G; Zhang H; Sun M; Li C; Hou Y; Li X; Meng F; Chen X
    Int J Gynecol Cancer; 2011 Jan; 21(1):92-9. PubMed ID: 21330834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.